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 Supplementary Figures
 Fig. S1. Cell shape change, migration, and proliferation are unicellular behaviors adopted 
for multicellular branching 
Multicellular tissues across species employ different combinations of cell shape change, cell 
migration, and proliferation to undergo branching morphogenesis. For each branching 
structure in the table, + indicates the presence of a specific behavior and – indicates its 
absence.  












































      Fig. S2. serca RNAi disrupts Drosophila larval air sac budding after depleting serca mRNA 
and Ca2+ stores 
  (A) Each configuration of da-GAL4 driven serca RNAi reduced serca mRNA levels relative to 
18S when compared to wild-type (w1118). 
 (B) Cells were dissociated from stage 16 wild-type and da> serca RNAi Drosophila embryos. 
 (C) The air sacs are visualized by btl-driven GFP expression. Compared to the control ‘leaf and 
Compared to wild-type Drosophila cells (left), RNAi cells (right) have deficient SERCA 
protein function by late embryogenesis featuring a subnormal rise in intracellular Ca2+ 
(measured by Ca2+ indicator fluorescence intensity) upon thapsigargin challenge. 
stalk’ type structure, btl-GAL4 driven serca RNAi +/- dicer induced a range of phenotypes, 
from no budding to very stunted and dysmorphic buds without the typical stalk. Combining 
RNAi constructs (4474 and 107446) to enhance the knockdown further increased the 
frequency of severely deranged air sac morphogenesis (Scale bar: 25 µm). Bottom panels are 
three representative examples. Control image is repeated from Fig. 1A.












































     Fig. S3. serca RNAi does not affect apoptosis rate in larval air sac primordia 
Confocal micrographs show third instar larval imaginal wing discs, with tracheal system in 
green (actin-GFP) and apoptotic cells labeled by cleaved Caspase-3 in magenta. Scale bars: 
20 µm. 
     (A) Wild-type control air sac primordia.  
         (B) Mutant serca RNAi air sac primordia, arrow indicates one apoptotic cell outside the air sac.         
    (C) Positive control showing Caspase-3-positive cells in the wing disc border. 
         (D) Table shows number of air sac primordia imaged for each genotype, and total number of 
cleaved Caspase-3-positive cells detected within the air sacs across all samples: no apoptotic 
cells were seen in wild-type air sacs, and only a single apoptotic cell was seen in one of 22 
mutant air sacs. 













































 Fig. S4. RNAi is not sufficient to disrupt SERCA protein levels or function during early  
Drosophila embryogenesis 
  (A)    qRT-PCR of stage 11 wild-type embryos (w1118) or embryos ubiquitously expressing RNAi 
constructs (4474, 107446, 4474+dicer2, or 4474+107446) using the da-Gal4 driver to knock 
down serca does not deplete serca mRNA relative to 18S mRNA. (Error bars indicate +/- 1 
SEM.) 
 (B) In da-Gal4 X sercaRNAi4474 / CyO-twi>GFP embryos, when GFP is not expressed, the RNA 
construct against serca is ubiquitously expressed. Confocal micrographs show ubiquitous 
expression of SERCA protein (red, fluorescent thapsigargin) in controls (left side) and with 
RNAi construct expression (right side), at stage 11. 
 (C) Cells were dissociated from stage 11 wild type and da> serca RNAi Drosophila embryos. 
Compared to wild type Drosophila cells (left), RNAi cells (right) have normal SERCA 
protein function (mean +/- SD) with a normal rise in intracellular Ca2+ (measured by Ca2+ 
indicator fluorescence intensity) upon thapsigargin challenge.  












































   Fig. S5 SERCA inhibition with CPA creates physical gaps in tracheal trunks, but these are 
          not due to cell death, and tracheal structure is rescued by PKC activation 
   Tracheal cells are genetically labeled by Breathless (Btl) driving eGFP fused to actin. The dorsal
          trunk is outlined with dotted yellow lines in each panel. Scale bar: 50 µm throughout. 
      (A)  Control embryos treated with DMSO. 
    (B) Incubation with SERCA inhibitor CPA results in physical gaps in the dorsal trunk where 
tracheal cells are absent (arrowhead) and tenuous cytoplasmic connections between segments
(arrow). 
(C) Removal of CPA at stage 12 and further incubation without the inhibitor results in fewer 
gaps (solid arrowhead) but exuberant sprouting (open arrowheads) and undulating branches. 
Sometimes an extranumerary lateral trunk partially or completely forms (arrows). 
   (D)  Treatment with PKC activator PMA alone results in normal tracheal structure. 
   (E) Co-treatment with SERCA inhibitor and PKC activator rescues tracheal structure. 
   (F) In live embryos, fluorescently labeled nuclei of tracheal cells were tracked in controls treated 
with DMSO, and in CPA-treated embryos at segments where a continuous lateral trunk failed 
to form. From stages 14-16 during the time the lateral trunk should have formed, there was 
no tracheal cell death observed in either CPA- or DMSO-treated embryos. All labeled nuclei 
remained present throughout; at affected segments in the CPA-treated embryos, the cells 
simply did not migrate to form the trunk.  






















 Fig. S6. SERCA blockade with CPA elevates overall Ca2+ level of Drosophila tracheal cells 
     (A-C) For DMSO-treated (A), CPA-treated (B), and CPA+PMA-treated (C) embryos, three 
representative pairs of leader (blue) and trailer (magenta) cells are plotted together. Ca2+ level 
is consistently higher in leader cells in A and C, while this differential is reversed in CPA-
treated embryos (B). Also, the overall Ca2+ levels of the tracheal cells in the CPA-treated 
embryos are higher than in the DMSO- and CPA+PMA-treated embryos, consistent with 
blockade of the SERCA pump. This is alleviated by co-treatment with PKC-activator PMA 
(C).  












































 Fig. S7. SERCA inhibition induces Drosophila neural phenotypes that are rescued by PMA 
      (A-D) Permeablized embryos are seen at stage 15-16 after incubation with (A) DMSO (control), 
 (E) Normal and disrupted regions of the Drosophila nerve tracts intersperse following SERCA 
inhibition. Three examples of permeablized Drosophila embryos treated with 20 µM CPA and 
immunostained with antibody against FasII display a range of neural phenotypes. Aberrant 
neural branching revealed by midline crossings, merged longitudinal tracts, or discontinuities 
(red arrowheads) occur adjacent to sections of the nerve tracts and peripheral nerve projections 
that display relatively normal structure (white arrowheads).  This abrupt juxtaposition of 
normal and disrupted branching, and the ability to perturb all parts of the nerve cord when 
multiple embryos are considered collectively, support a cell-autonomous role for SERCA in 
neural guidance.  This is consistent with disrupted neural pathfinding in cells that take up a 
sufficient amount of SERCA inhibitor, and unperturbed pathfinding in cells that happen to 
acquire minimal inhibitor.  Scale bar: 40 µm.  
(B) 20 µM CPA, (C) 20 µM CPA with washout and (D) 20 µM CPA and 100 nM PMA. 
Neural structure is demonstrated by FasII immunostaining. SERCA-inhibited embryos (B) 
frequently display discontinuities and merged or aberrantly spaced FasII tracks (red 
arrowheads) throughout the central nervous system. Merging of tracks frequently seen at the 
level of A4-A5 (red arrow in B) may also reflect perturbed cell migration during germ band 
retraction, since migration problems typically manifest in these segments. Severity of neural 
perturbation at stage 15-16 is reduced by washout of CPA at stage 12 (C) and rescued by co-
incubation with PMA (D).  n > 30 per treatment group. Scale bar: 40 µm. 












































Fig. S8. Inhibition of Ca2+-dependent mechanotransduction neither reprises nor alleviates 
the SERCA inhibition phenotype 
Mammalian lung epithelial tips isolated from E12.5 murine lungs bud in Matrigel with FGF10 
(control) (A, image repeated from Fig. 6G leftmost panel). Lung tips were likewise cultured 
without or with SERCA inhibitor (10 µM CPA) and in the presence of specific inhibitors of: 
(B) PKC (2.2 µM Bisindolylmaleimide I Hydrochloride), (C) PLC (10 µM L108), (D) ROCK 
(20 µM Y-26732), or (E) RAC (12.5 µM NSC 23766). None of these inhibitors recreated or 
mitigated the phenotype of SERCA inhibition with CPA. Scale bars: 100 μm.






















Fig. S9.  SERCA inhibition does not disrupt epithelial geometry 
Confocal images of phalloidin-stained epithelia from mouse lung or Drosophila air sac were 
skeletonized computationally to calculate cell areas and perimeters and for scoring cell 
sidedness. 
   (A) Square root of cell area vs perimeter for cells in murine epithelial lung tips cultured with 10 
µM CPA (red) or without (+). 
(B)  Frequency distributions show no differences in the number of sides for wild-type epithelial tip 
cells compared to those treated with 10 µM CPA +/- 100 nM PMA. 
 (C) Square root of cell area vs perimeter for cells in Drosophila air sac with targeted serca RNAi 
(red) or without (+). 
 (D) Frequency distributions show no differences in the number of sides for epithelial cells in 
wildtype Drosophila air sacs compared to those in serca RNAi air sacs. 
















































Movies 3‐11: Dynamic Ca2+ imaging of Drosophila tracheogenesis. Two‐photon light‐sheet microscopy  
was used to image permeablized Drosophila embryos expressing the Ca2+ indicator GCamP3, from 
stage 13 to 16 (timepoints 3 seconds apart), during treatment with DMSO, 20 μM CPA, or 20 μM CPA + 
















squiggly tails indicate their path over the previous 10 time steps. Scale bars: 30 μm.
Movie 1: In the representative DMSO-treated control embryo, cells from adjacent segments converge to 
form the lateral trunk.
Movie 2: In the representative CPA-treated mutant embryo, these lateral trunk cells continue moving in 
parallel so that the gap between them persists, leading to a fragmented tracheal structure (movies run to 
stage 16).
*Movie 1b follows the embryo in Movie 1 from stage 12 through late 16.














































































































































































































exhibits a visibly higher Ca2+ level than the trailing cell (magenta).  Scale bar: 10 μm.
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